Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics Statistics

Total Valuation

SAGE has a market cap or net worth of $428.95 million. The enterprise value is $16.95 million.

Market Cap	428.95M
Enterprise Value	16.95M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025, after market close.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

SAGE has 62.62 million shares outstanding. The number of shares has increased by 2.08% in one year.

Current Share Class	62.62M
Shares Outstanding	62.62M
Shares Change (YoY)	+2.08%
Shares Change (QoQ)	+0.97%
Owned by Insiders (%)	0.44%
Owned by Institutions (%)	77.12%
Float	51.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.84
Forward PS	4.79
PB Ratio	1.05
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.13, with a Debt / Equity ratio of 0.03.

Current Ratio	9.13
Quick Ratio	8.78
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.53% and return on invested capital (ROIC) is -39.77%.

Return on Equity (ROE)	-63.53%
Return on Assets (ROA)	-36.35%
Return on Invested Capital (ROIC)	-39.77%
Return on Capital Employed (ROCE)	-85.68%
Revenue Per Employee	$134,289
Profits Per Employee	-$1.00M
Employee Count	353
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.56% in the last 52 weeks. The beta is 0.18, so SAGE's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-37.56%
50-Day Moving Average	7.10
200-Day Moving Average	6.93
Relative Strength Index (RSI)	51.14
Average Volume (20 Days)	764,497

Short Selling Information

The latest short interest is 5.01 million, so 8.01% of the outstanding shares have been sold short.

Short Interest	5.01M
Short Previous Month	4.67M
Short % of Shares Out	8.01%
Short % of Float	9.80%
Short Ratio (days to cover)	5.55

Income Statement

In the last 12 months, SAGE had revenue of $47.40 million and -$354.40 million in losses. Loss per share was -$5.79.

Revenue	47.40M
Gross Profit	-138.35M
Operating Income	-359.78M
Pretax Income	-445.67M
Net Income	-354.40M
EBITDA	-358.98M
EBIT	-359.78M
Loss Per Share	-$5.79

Balance Sheet

The company has $423.85 million in cash and $11.86 million in debt, giving a net cash position of $412.00 million or $6.58 per share.

Cash & Cash Equivalents	423.85M
Total Debt	11.86M
Net Cash	412.00M
Net Cash Per Share	$6.58
Equity (Book Value)	409.85M
Book Value Per Share	6.55
Working Capital	404.70M

Cash Flow

Operating Cash Flow	-311.09M
Capital Expenditures	n/a
Free Cash Flow	-311.09M
FCF Per Share	-$4.97

Margins

Gross Margin	-291.84%
Operating Margin	-758.97%
Pretax Margin	-747.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SAGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.08%
Shareholder Yield	-2.08%
Earnings Yield	-82.62%
FCF Yield	-72.52%

Analyst Forecast

The average price target for SAGE is $9.88, which is 44.23% higher than the current price. The consensus rating is "Hold".

Price Target	$9.88
Price Target Difference	44.23%
Analyst Consensus	Hold
Analyst Count	19
Revenue Growth Forecast (5Y)	41.46%
EPS Growth Forecast (5Y)	-37.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SAGE has an Altman Z-Score of -5.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.04
Piotroski F-Score	1